---
title: "Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: Terms and abbreviations"
description: "Formulary evidence on Lonvoguran ziclumeran (lonvo-z, NTLA-2002) in Hereditary angioedema: Terms and abbreviations. 1 evidence topic quoted from 0 sources."
canonical: "https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/terms-and-abbreviations"
published: "2026-09-14T15:39:06-04:00"
modified: "2026-11-17T19:46:25-05:00"
---

# Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: Terms and abbreviations

<a id="terms-and-abbreviations"></a>

## Terms and Abbreviations

<a id="topic-terms-and-abbreviations-1"></a>

| Abbreviation | Term |
| --- | --- |
| ACAAI | American College of Allergy, Asthma & Immunology |
| AE | Adverse event |
| AE-QoL | Angioedema Quality of Life Questionnaire |
| AHFS | American Hospital Formulary Service |
| ALT | Alanine aminotransferase |
| BLA | Biologics license application |
| C1-INH | C1 esterase inhibitor |
| C1INH | C1 esterase inhibitor |
| CI | Confidence interval |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| EAACI | European Academy of Allergy and Clinical Immunology |
| ED | Emergency department |
| FDA | Food and Drug Administration |
| FFP | Fresh frozen plasma |
| FXII | Coagulation factor XII |
| FXIIa | Activated coagulation factor XII |
| HADS | Hospital Anxiety and Depression Scale |
| HAE | Hereditary angioedema |
| HAE-FXII | Hereditary angioedema associated with a factor XII gene variant |
| HAE-nC1INH | Hereditary angioedema with normal C1 inhibitor |
| HAE-PLG | Hereditary angioedema associated with a plasminogen gene variant |
| HRQoL | Health-related quality of life |
| IV | Intravenous |
| KKS | Kallikrein-kinin system |
| KLKB1 | Kallikrein B1 gene |
| LNP | Lipid nanoparticle |
| LP01 | Ionizable lipid component of NTLA-2002 |
| LTFU | Long-term follow-up |
| LTP | Long-term prophylaxis |
| MCID | Minimal clinically important difference |
| mRNA | Messenger RNA |
| NHP | Nonhuman primate |
| ODT | On-demand treatment |
| PD | Pharmacodynamics |
| pdC1INH | Plasma-derived C1 inhibitor |
| PDUFA | Prescription Drug User Fee Act |
| PK | Pharmacokinetics |
| PRIME | Priority Medicines |
| PRO | Patient-reported outcome |
| QALY | Quality-adjusted life-year |
| QoL | Quality of life |
| RMAT | Regenerative Medicine Advanced Therapy |
| RNA | Ribonucleic acid |
| RWE | Real-world evidence |
| SC | Subcutaneous |
| SD | Standard deviation |
| TEAE | Treatment-emergent adverse event |
| WAO | World Allergy Organization |
| WPAI | Work Productivity and Activity Impairment questionnaire |

## Related pages
- [Lonvoguran ziclumeran (lonvo-z): Hereditary angioedema](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema.md)
- [Lonvoguran ziclumeran (lonvo-z): Hereditary angioedema](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/executive-summary.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: Product information and disease description](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/product-information-and-disease-description.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: Clinical evidence](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/clinical-evidence.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: Economic information and modeling report](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/economics) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/economics.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: References](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/references) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/references.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: prevalence by geography](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/prevalence) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/prevalence.md)
- [Lonvoguran ziclumeran (lonvo-z) in Hereditary angioedema: cost-effectiveness analyses and utility weights](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/cost-effectiveness-analyses) · [Markdown](https://www.evicenter.com/drugs/lonvoguran-ziclumeran--hereditary-angioedema/cost-effectiveness-analyses.md)
